Association between Rates of Retinal Nerve Fiber Layer Thinning after Intraocular Pressure-Lowering Procedures and Disc Hemorrhage.


Journal

Ophthalmology. Glaucoma
ISSN: 2589-4196
Titre abrégé: Ophthalmol Glaucoma
Pays: United States
ID NLM: 101730510

Informations de publication

Date de publication:
Historique:
entrez: 8 7 2020
pubmed: 8 7 2020
medline: 7 9 2021
Statut: ppublish

Résumé

To compare the rates of retinal nerve fiber layer (RNFL) thinning after intraocular pressure (IOP) lowering procedures in eyes with or without disc hemorrhage (DH) history. Observational cohort study. A total of 166 primary open angle glaucoma (POAG) eyes and glaucoma suspect eyes (37 eyes with DH history (DH group) and 129 eyes without DH (non-DH group)) were included from the African Decent and Glaucoma Evaluation Study (ADAGES) and the Diagnostic Innovations in Glaucoma Study (DIGS). Subjects underwent stereoscopic optic disc photography annually and spectral-domain optical coherence tomography (OCT) RNFL thickness measurements every 6 months. The rates of RNFL thinning were compared in eyes with and without DH using univariate and multivariable linear mixed effects models. The rates of RNFL thinning. The mean follow-up of DH group and non-DH group was 4.6 years and 4.2 years, respectively. DH group had more procedures (2.4 vs. 1.9, POAG or glaucoma suspect eyes with a history of DH should be carefully followed after IOP-lowering procedures. Additional IOP-lowering may be needed to slow structural progression of the DH eyes to the same rate as the non-DH eyes.

Identifiants

pubmed: 32632404
doi: 10.1016/j.ogla.2019.11.002
pmc: PMC7337275
mid: NIHMS1543064
doi:

Types de publication

Journal Article Multicenter Study Observational Study Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

7-13

Subventions

Organisme : NEI NIH HHS
ID : R01 EY011008
Pays : United States
Organisme : NEI NIH HHS
ID : R01 EY029058
Pays : United States
Organisme : NEI NIH HHS
ID : P30 EY022589
Pays : United States
Organisme : NEI NIH HHS
ID : R01 EY019869
Pays : United States
Organisme : NEI NIH HHS
ID : R01 EY027510
Pays : United States
Organisme : NEI NIH HHS
ID : U10 EY014267
Pays : United States
Organisme : NEI NIH HHS
ID : R01 EY026574
Pays : United States

Références

Ophthalmology. 2012 Apr;119(4):731-7
pubmed: 22264886
Graefes Arch Clin Exp Ophthalmol. 2010 Jun;248(6):839-44
pubmed: 20182885
Am J Ophthalmol. 2003 Nov;136(5):820-9
pubmed: 14597032
Ophthalmology. 2008 Nov;115(11):2044-8
pubmed: 18692244
Ophthalmology. 2013 Dec;120(12):2485-2492
pubmed: 23993360
Ophthalmology. 2016 Oct;123(10):2058-65
pubmed: 27554036
Can J Ophthalmol. 2017 Dec;52(6):583-591
pubmed: 29217027
Prog Retin Eye Res. 2017 Sep;60:20-43
pubmed: 28864288
Arch Ophthalmol. 1997 Oct;115(10):1257-62
pubmed: 9338670
Ophthalmology. 2014 Jul;121(7):1350-8
pubmed: 24629619
Ophthalmology. 2010 Nov;117(11):2061-6
pubmed: 20541265
Curr Opin Ophthalmol. 2017 Mar;28(2):105-112
pubmed: 27820751
Ophthalmology. 2006 Apr;113(4):598-602
pubmed: 16488014
Arch Ophthalmol. 2012 Dec;130(12):1541-6
pubmed: 23229692
Prog Retin Eye Res. 2002 Jan;21(1):35-56
pubmed: 11906810
Ophthalmology. 2004 Sep;111(9):1653-7
pubmed: 15350318
Br J Ophthalmol. 2015 Jan;99(1):21-5
pubmed: 25057184
Ophthalmology. 1995 Mar;102(3):365-6
pubmed: 7891969
Arch Ophthalmol. 2009 Sep;127(9):1136-45
pubmed: 19752422
JAMA. 2014 May 14;311(18):1901-11
pubmed: 24825645
Graefes Arch Clin Exp Ophthalmol. 2012 Apr;250(4):583-7
pubmed: 21947302
Ophthalmology. 2017 Sep;124(9):1403-1411
pubmed: 28499748
Ophthalmology. 1994 Jul;101(7):1165-72
pubmed: 8035978
Invest Ophthalmol Vis Sci. 2009 Oct;50(10):4727-33
pubmed: 19458330
Ophthalmology. 2006 Dec;113(12):2137-43
pubmed: 16996592
J Glaucoma. 2006 Apr;15(2):164-71
pubmed: 16633231
J Glaucoma. 2012 Aug;21(6):358-66
pubmed: 21623225

Auteurs

Huiyuan Hou (H)

Hamilton Glaucoma Center, Shiley Eye Institute, Department of Ophthalmology, University of California San Diego, La Jolla, CA.

Sasan Moghimi (S)

Hamilton Glaucoma Center, Shiley Eye Institute, Department of Ophthalmology, University of California San Diego, La Jolla, CA.

Linda M Zangwill (LM)

Hamilton Glaucoma Center, Shiley Eye Institute, Department of Ophthalmology, University of California San Diego, La Jolla, CA.

James A Proudfoot (JA)

Hamilton Glaucoma Center, Shiley Eye Institute, Department of Ophthalmology, University of California San Diego, La Jolla, CA.

Tadamichi Akagi (T)

Hamilton Glaucoma Center, Shiley Eye Institute, Department of Ophthalmology, University of California San Diego, La Jolla, CA.
Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan.

Takuhei Shoji (T)

Hamilton Glaucoma Center, Shiley Eye Institute, Department of Ophthalmology, University of California San Diego, La Jolla, CA.
Department of Ophthalmology, Saitama Medical University, Saitama, Japan.

Christopher A Girkin (CA)

Department of Ophthalmology, University of Alabama, Birmingham, Alabama.

Jeffrey M Liebmann (JM)

Department of Ophthalmology, New York Eye and Ear Infirmary, New York, New York.

Robert N Weinreb (RN)

Hamilton Glaucoma Center, Shiley Eye Institute, Department of Ophthalmology, University of California San Diego, La Jolla, CA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH